Dr Reddy's Laboratories Q2 2025 GAAP EPS $0.18 Compared To $0.21 YoY, Sales $957.00M Compared To $821M YoY
Dr Reddy's Laboratories Q2 2025 GAAP EPS $0.18 Compared To $0.21 YoY, Sales $957.00M Compared To $821M YoY
Dr Reddy的实验室2025年第二季度GAAP每股收益为0.18美元，同比下降至0.21美元，销售额为95700万美元，同比上升至82100万美元
Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.18 per share which missed the analyst consensus estimate of $84.03 by 99.79 percent. This is a 14.29 percent decrease over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $957.00 million which missed the analyst consensus estimate of $76.49 billion by 98.75 percent. This is a 16.57 percent increase over sales of $821.00 million the same period last year.
雷迪博士实验室（纽约证券交易所代码：RDY）公布的季度收益为每股0.18美元，比分析师共识预期的84.03美元低99.79％。与去年同期的每股收益0.21美元相比，下降了14.29％。该公司公布的季度销售额为9.57亿美元，比分析师共识估计的764.9亿美元低98.75％。这比去年同期的8.21亿美元销售额增长了16.57％。
资讯热榜
更新时间